Applied Health Economics and Health Policy

2008 - 2025

Current editor(s): Timothy Wrightson

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 18, issue 6, 2020

Health Financing in Sub-Saharan Africa: From Analytical Frameworks to Empirical Evaluation pp. 743-746

Augustine Asante, Wilson S. K. Wasike and John Ataguba

An Alternative Approach to Decomposing the Redistributive Effect of Health Financing Between and Within Groups Using the Gini Index: The Case of Out-of-Pocket Payments in Nigeria pp. 747-757

John Ataguba, Hyacinth E. Ichoku, Chijioke O. Nwosu and James Akazili

Evaluating Equity in Health Financing Using Benefit Incidence Analysis: A Framework for Accounting for Quality of Care pp. 759-766

Augustine Asante, Nicola Man and Virginia Wiseman

Analyzing the Financial Sustainability of User Fee Removal Policies: A Rapid First Assessment Methodology with a Practical Application for Burkina Faso pp. 767-780

Jacky Mathonnat, Martine Audibert and Salam Belem

Estimating Catastrophic Health Expenditures from Household Surveys: Evidence from Living Standard Measurement Surveys (LSMS)-Integrated Surveys on Agriculture (ISA) from Sub-Saharan Africa pp. 781-788

Sarah Ssewanyana and Ibrahim Kasirye

An Assessment of Domestic Financing for Reproductive, Maternal, Neonatal and Child Health in Sub-Saharan Africa: Potential Gains and Fiscal Space pp. 789-799

Chris Atim, Eric Arthur, Daniel Malik Achala and Jacob Novignon

Performance-Based Financing, Basic Packages of Health Services and User-Fee Exemption Mechanisms: An Analysis of Health-Financing Policy Integration in Three Fragile and Conflict-Affected Settings pp. 801-810

Eelco Jacobs, Maria Paola Bertone, Jurrien Toonen, Ngozi Akwataghibe and Sophie Witter

Payment Arrangements for Private Healthcare Purchasing Under Publicly Funded Systems in Low- and Middle-Income Countries: Issues and Implications pp. 811-823

Ayako Honda and Amarech Obse

Health Insurance in Sub-Saharan Africa: A Scoping Review of the Methods Used to Evaluate its Impact pp. 825-840

Stéphanie Degroote, Valery Ridde and Manuela Allegri

Volume 18, issue 5, 2020

The Inclusion of Comparative Environmental Impact in Health Technology Assessment: Practical Barriers and Unintended Consequences pp. 597-599

Brita A. K. Pekarsky

Modeling Medicaid and Medicare Savings from Reduced Poverty and Disability to Promote Investment in Mental Health and Substance Use Interventions in the USA pp. 601-604

Nathaniel Z. Counts, Paul Gionfriddo and Richard H. Chapman

Health Promoting Schools: An Update pp. 605-623

Albert Lee, Amelia Lo, Queenie Li, Vera Keung and Amy Kwong

A Systematic Review of the Association Between Hospital Cost/price and the Quality of Care pp. 625-639

Sara Jamalabadi, Vera Winter and Jonas Schreyögg

Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review pp. 641-654

Bernard O. Okeah and Colin H. Ridyard

Effects of Monetary Incentives in Physician Groups: A Systematic Review of Reviews pp. 655-667

Ann-Kathrin Heider and Harald Mang

The Potential Benefits of Deferred Payment for a Hypothetical Gene Therapy for Congestive Heart Failure: A Cost-Consequence Analysis pp. 669-677

Jakub Hlavka, Soeren Mattke and Asa Wilks

Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases pp. 679-687

Anh Dam Tran, Gerald Fogarty, Anna K. Nowak, Vakaramoko Diaby, Angela Hong, Caroline Watts and Rachael L. Morton

Preferences for Weight Loss Treatment Amongst Treatment-Seeking Patients with Severe Obesity: A Discrete Choice Experiment pp. 689-698

Michelle Queally, Edel Doherty, Francis Finucane and Ciaran O’Neill

Estimating the Unit Costs of Healthcare Service Delivery in India: Addressing Information Gaps for Price Setting and Health Technology Assessment pp. 699-711

Pankaj Bahuguna, Lorna Guinness, Sameer Sharma, Akashdeep Singh Chauhan, Laura Downey and Shankar Prinja

Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact pp. 713-726

Michael Laxy, Ping Zhang, Boon Peng Ng, Hui Shao, Mohammed K. Ali, Ann Albright and Edward W. Gregg

Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy pp. 727-737

Kim Edmunds, Penny Reeves, Paul Scuffham, Daniel A. Galvão, Robert U. Newton, Mark Jones, Nigel Spry, Dennis R. Taaffe, David Joseph, Suzanne K. Chambers and Haitham Tuffaha

Comment on: “The Italian NHS: What Lessons to Draw from COVID-19?” pp. 739-741

Davide Golinelli, Andrea Bucci, Kadjo Yves Cedric Adja and Fabrizio Toscano

Volume 18, issue 4, 2020

The Potential Role of Constrained Optimization Methods in Healthcare Decision Making pp. 461-462

William H. Crown

The Italian NHS: What Lessons to Draw from COVID-19? pp. 463-466

Livio Garattini, Michele Zanetti and Nicholas Freemantle

Should Health Economic Evaluations Undertaken from a Societal Perspective Include Net Government Spending Multiplier Effects? pp. 467-475

Jonathan Karnon and Brita Pekarsky

Do Research Groups Align on an Intervention’s Value? Concordance of Cost-Effectiveness Findings Between the Institute for Clinical and Economic Review and Other Health System Stakeholders pp. 477-489

Matthew Sussman, Jeffrey C. Yu and Joseph Menzin

Economic Evaluations of Anticancer Drugs Based on Medico-Administrative Databases: A Systematic Literature Review pp. 491-508

Elsa Bouée-Benhamiche, Philippe Jean Bousquet and Salah Ghabri

The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis pp. 509-517

Vincenzo Alfano and Salvatore Ercolano

Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project pp. 519-531

Baudouin Standaert, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen, Sandra Talbird, Katherine Hicks, Justin Carrico and Philip O. Buck

Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA pp. 533-545

Mustafa Oguz, Tereza Lanitis, Xiaoyan Li, Gail Wygant, Daniel E. Singer, Keith Friend, Patrick Hlavacek, Andreas Nikolaou and Soeren Mattke

Health State Values of Deaf British Sign Language (BSL) Users in the UK: An Application of the BSL Version of the EQ-5D-5L pp. 547-556

Gemma E. Shields, Katherine D. Rogers, Alys Young, Sofia Dedotsi and Linda M. Davies

Comparison of Utilization Trends between Biosimilars and Generics: Lessons from the Nationwide Claims Data in South Korea pp. 557-566

Hye-Jae Lee, Euna Han and Hyero Kim

Cost–Utility of Internet-Based Cognitive Behavioral Therapy in Unipolar Depression: A Markov Model Simulation pp. 567-578

Mathias Baumann, Tom Stargardt and Simon Frey

Estimating the Productivity Burden of Pediatric Pneumococcal Disease in Thailand pp. 579-587

Thanpisit Ounsirithupsakul, Piyameth Dilokthornsakul, Khachen Kongpakwattana, Zanfina Ademi, Danny Liew and Nathorn Chaiyakunapruk

What Matters to Potential Patients in Chemotherapy Service Delivery? A Discrete Choice Experiment pp. 589-596

Richard Norman, Matthew Anstey, Arman Hasani, Ian Li and Suzanne Robinson

Volume 18, issue 3, 2020

COVID-19 Pandemic, a War to be Won: Understanding its Economic Implications for Africa pp. 325-328

John Ataguba

A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic pp. 329-331

Jonathan Karnon

Why Only Test Symptomatic Patients? Consider Random Screening for COVID-19 pp. 333-334

William V. Padula

The Case for a Temporary COVID-19 Income Tax Levy Now, During the Crisis pp. 335-337

Jonathan Karnon

Impact of a Global Pandemic on Health Technology Assessment pp. 339-343

Paula Lorgelly and Amanda Adler

Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19 pp. 345-350

Moslem Soofi, Farid Najafi and Behzad Karami-Matin

The Relevant Perspective of Economic Evaluations Informing Local Decision Makers: An Exploration in Weight Loss Services pp. 351-356

Sebastian Hinde, Louise Horsfield, Laura Bojke and Gerry Richardson

Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition pp. 357-362

Rosella Levaggi and Paolo Pertile

iFuse Implant System for Treating Chronic Sacroiliac Joint Pain: A NICE Medical Technology Guidance pp. 363-373

Megan Dale, James Evans, Kimberley Carter, Susan O’Connell, Helen Morgan and Grace Carolan-Rees

Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists pp. 375-392

Chiranjeev Sanyal and Don Husereau

Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India pp. 393-411

Pankaj Bahuguna, Shankar Prinja, Chandrakant Lahariya, Radha Krishan Dhiman, Madhumita Prem Kumar, Vineeta Sharma, Arun Kumar Aggarwal, Rajesh Bhaskar, Hilde Graeve and Henk Bekedam

Promoting HIV Testing by Men: A Discrete Choice Experiment to Elicit Preferences and Predict Uptake of Community-based Testing in Uganda pp. 413-432

Elisabeth M. Schaffer, Juan Marcos Gonzalez, Stephanie B. Wheeler, Dalsone Kwarisiima, Gabriel Chamie and Harsha Thirumurthy

Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT® Re-usable Inhaler pp. 433-442

Gustaf Ortsäter, Fredrik Borgström, Mike Baldwin and Carolin Miltenburger

The Impact of Physicians’ Working Hours on Inappropriate Use of Outpatient Medicine in a Tertiary Hospital in China pp. 443-451

Xiaodong Guan, Bingyu Ni, Jingyuan Zhang, Chunxia Man, Zheng Cai, Wenshuang Meng, Luwen Shi and Dennis Ross-Degnan

Comment on: ‘Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition’ pp. 453-454

Livio Garattini and Nick Freemantle

Authors’ Reply to Garattini and Freemantle: “Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition” pp. 455-456

Rosella Levaggi and Paolo Pertile

Comment on: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance” pp. 457-458

J. P. Hays

Authors’ Reply to Hays: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance” pp. 459-460

David J. Mott, Grace Hampson, Martin J. Llewelyn, Jorge Mestre-Ferrandiz and Michael M. Hopkins

Volume 18, issue 2, 2020

Economics of Mental Health: Providing a Platform for Efficient Mental Health Policy pp. 143-145

Christopher M. Doran and Irina Kinchin

Mental health: A Particular Challenge Confronting Policy Makers and Economists pp. 147-153

Peter Zweifel

Universal Mental Health Interventions for Children and Adolescents: A Systematic Review of Health Economic Evaluations pp. 155-175

Masja Schmidt, Amber Werbrouck, Nick Verhaeghe, Koen Putman, Steven Simoens and Lieven Annemans

Healthcare Costs for People with Serious Mental Illness in England: An Analysis of Costs Across Primary Care, Hospital Care, and Specialist Mental Healthcare pp. 177-188

Jemimah Ride, Panagiotis Kasteridis, Nils Gutacker, Maria Jose Aragon Aragon and Rowena Jacobs

Evaluating the Cost Effectiveness of a Suicide Prevention Campaign Implemented in Ontario, Canada pp. 189-201

Michael Lebenbaum, Joyce Cheng, Claire Oliveira, Paul Kurdyak, Juveria Zaheer, Rebecca Hancock-Howard and Peter C. Coyte

The Evolution of Mental Health in the Context of Transitory Economic Changes pp. 203-221

Alexandrina Stoyanova and Jaime Pinilla

Socioeconomic Disparities in Unmet Need for Student Mental Health Services in Higher Education pp. 223-235

John Cullinan, Sharon Walsh and Darragh Flannery

Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial pp. 237-247

David M. Meads, Adam Martin, Alys Griffiths, Rachael Kelley, Byron Creese, Louise Robinson, Joanne McDermid, Rebecca Walwyn, Clive Ballard and Claire A. Surr

The Impact of Ghana’s National Health Insurance on Psychological Distress pp. 249-259

Gowokani Chirwa, Marc Suhrcke and Rodrigo Moreno-Serra

Implicitly Estimating the Cost of Mental Illness in Australia: A Standard-of-Living Approach pp. 261-270

Hong Son Nghiem, Rasheda Khanam, Binh (Benjamin) Vu and Bach Xuan Tran

Cost-Effectiveness of a School-Based Social and Emotional Learning Intervention: Evidence from a Cluster-Randomised Controlled Trial of the Promoting Alternative Thinking Strategies Curriculum pp. 271-285

Alex J. Turner, Matt Sutton, Mark Harrison, Alexandra Hennessey and Neil Humphrey

Costs of Mental Health Services in Czechia: Facilitating an Evidence-Based Reform of Psychiatric Care pp. 287-298

Hana M. Broulíková, Petr Winkler, Marek Páv and Lucie Kondrátová

Assessing Horizontal Equity in the Utilization of Mental Healthcare Services in Turkey: A Gender Perspective pp. 299-309

Dilek Başar and Selcen Öztürk

Program Evaluation and Decision Analytic Modelling of Universal Suicide Prevention Training (safeTALK) in Secondary Schools pp. 311-324

Irina Kinchin, Alex M. T. Russell, Dennis Petrie, Adrianne Mifsud, Laurence Manning and Christopher M. Doran

Volume 18, issue 1, 2020

Improving Decision-Making Processes in Health: Is It Time for (Disease-Specific) Reference Models? pp. 1-4

Hossein Haji Ali Afzali, Laura Bojke and Jonathan Karnon

Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab pp. 5-16

Caridad Pontes, Corinne Zara, Josep Torrent-Farnell, Merce Obach, Cristina Nadal, Patricia Vella-Bonanno, Michael Ermisch, Steven Simoens, Renata Curi Hauegen, Jolanta Gulbinovic, Angela Timoney, Antony P. Martin, Tanja Mueller, Anna Nachtnebel, Stephen Campbell, Gisbert Selke, Tomasz Bochenek, Celia C. Rothe, Ileana Mardare, Marion Bennie, Jurij Fürst, Rickard E. Malmstrom and Brian Godman

Determining the Baseline Strategy in a Cost-Effectiveness Analysis with Treatment Sequences pp. 17-29

Marta Giulia Viola and Alexander Diamantopoulos

Using the Threshold Technique to Elicit Patient Preferences: An Introduction to the Method and an Overview of Existing Empirical Applications pp. 31-46

Brett Hauber and Joshua Coulter

Price Models for Multi-indication Drugs: A Systematic Review pp. 47-56

Carlos Campillo-Artero, Jaume Puig-Junoy, José Luis Segú-Tolsa and Marta Trapero-Bertran

Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System pp. 57-68

Ângela J. Ben, Jeruza L. Neyeloff, Camila F. Souza, Ana Paula O. Rosses, Aline L. Araujo, Adriana Szortika, Franciele Locatelli, Gabriela Carvalho and Cristina R. Neumann

A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance pp. 69-79

David Mott, Grace Hampson, Martin J. Llewelyn, Jorge Mestre-Ferrandiz and Michael M. Hopkins

Why Do Informal Sector Workers Not Pay the Premium Regularly? Evidence from the National Health Insurance System in Indonesia pp. 81-96

Teguh Dartanto, Alin Halimatussadiah, Jahen Rezki, Renny Nurhasana, Chairina Siregar, Hamdan Bintara, Usman, Wahyu Pramono, Nia Kurnia Sholihah, Edith Zheng Wen Yuan and Rooswanti Soeharno

Estimating Attribute-Specific Willingness-to-Pay Values from a Health Care Contingent Valuation Study: A Best–Worst Choice Approach pp. 97-107

Ivan Sever, Miroslav Verbič and Eva Klaric Sever

Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany pp. 109-125

Afschin Gandjour and Dennis A. Ostwald

Forecasting Ontario Oncology Drug Expenditures: A Hybrid Approach to Improving Accuracy pp. 127-137

Paula M. Murray, Yusuf A. Shalaby, Luciano Ieraci, Emmett Borg, Daphne Sniekers, Ali Vahit Esensoy and Jessica Arias

Comment on: “Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection Under Different Treatment Policies in Malaysia, 2018–2040” pp. 139-140

Muhammad Radzi Abu Hassan and Huan-Keat Chan

Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands pp. 141-141

Renée Else Michels, Maria Francesco, Koshu Mahajan, Gerald J. D. Hengstman, Krijn M. H. Schiffers, Sangeeta Budhia, Gerard Harty and Marieke Krol